Siemens Corporate Research for Healthcare

Goal: To identify and prioritize mid-term opportunities associated with the future of health care that account for existing and acquired capabilities following the acquisition of a diagnostic company.

Results:

1. •Evaluated a dozen technological gaps across drug discovery and development.
   

2. •Prioritized these opportunities by impact on corporate decisions in large pharmaceutical companies, by commercial value, and by the client’s competitive position in each area.
   

3. •Performed a detailed analysis of the top two opportunities, identified research investment opportunities, and provided warm introductions to initiate strategic partnering.
   

Becton, Dickinson and Company - A Global Medical Technology Company

Goal: To develop a process for managing ideas to drive R&D innovation.

Result:

1. •Developed an early-stage screening tool to quantify and rank new product and technology platform ideas.
   

2. •Built a stage and gate process for managing and testing the feasibility of highly-ranked ideas.
   

3. •Justified the creation of a new senior level position to manage all corporate idea flow and oversee evaluation of candidate ideas for endorsement and funding.
   

4. •Developed a new approach for performing voice of customer and voice of business surveys that would dramatically improve the identification of high-value, unmet medical diagnostic needs.
   

Ridge Diagnostics

Goal: To design and monitor a technology development roadmap for a novel diagnostics platform.

Result:

1. •Developed and successfully completed a research program to establish and validate first-in-class specifications for the beta and commercial versions of the instrument.
   

2. •Identified and prioritized three applications with high commercial value. Designed and monitored the successful development of these applications.
   

3. •Established a novel strategic partnership model between the client and a large pharmaceutical company that accelerated the development and acceptance of these new applications. This approach dramatically enhanced the capacity and capabilities of the engineering and application development functions for the client.
   

A Large Diagnostic Company

Goal: To assist the diagnostic division in making a decision upon investing in multiplex biomarker systems.

Result:

1. •Developed, optimized, and employed a questionnaire to determine how pharmaceutical executives use data from multiplexed protein biomarker assay platforms to make drug development decisions.
   

2. •Information from survey was used to define assay performance criteria, assay price points, levels of exclusivity, and market forecast projections.

Clients